Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-12098183-B2 · Sep 24, 2024 · US
This page is not indexed by search engines while we improve data quality.
Peper Janet patents
Peper Janet is listed as an inventor on 65 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Peper Janet |
| Total patents | 65 |
| First publication | Feb 9, 2017 |
| Latest publication | Sep 24, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-12065477-B2 · Aug 20, 2024 · US
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-2024076349-A1 · Mar 7, 2024 · US
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-11919940-B2 · Mar 5, 2024 · US
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-2024034769-A1 · Feb 1, 2024 · US
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-11858978-B2 · Jan 2, 2024 · US
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-11840562-B2 · Dec 12, 2023 · US
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
US-11819518-B2 · Nov 21, 2023 · US
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-2023365651-A1 · Nov 16, 2023 · US
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
US-11806366-B2 · Nov 7, 2023 · US
Recent patents
Latest publications not already listed above.
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-2023312680-A1 · Oct 5, 2023 · US
Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
US-2023285458-A1 · Sep 14, 2023 · US
Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
US-2023241106-A1 · Aug 3, 2023 · US
Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
US-2023241107-A1 · Aug 3, 2023 · US
Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
US-2023201259-A1 · Jun 29, 2023 · US
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
US-2023190813-A1 · Jun 22, 2023 · US
Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
US-2023086100-A1 · Mar 23, 2023 · US
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-2023002473-A1 · Jan 5, 2023 · US
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-2023002474-A1 · Jan 5, 2023 · US
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-2022356227-A1 · Nov 10, 2022 · US
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-11345737-B1 · May 31, 2022 · US
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
US-11278571-B2 · Mar 22, 2022 · US
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-11248035-B1 · Feb 15, 2022 · US
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
US-11246889-B2 · Feb 15, 2022 · US
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-11214608-B2 · Jan 4, 2022 · US
Novel fusion protein specific for cd137 and pd-l1
US-2021363257-A1 · Nov 25, 2021 · US
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-2021363221-A1 · Nov 25, 2021 · US
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-2021340216-A1 · Nov 4, 2021 · US
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
US-2021340217-A1 · Nov 4, 2021 · US
Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
US-2021260123-A1 · Aug 26, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Immatics Biotechnologies Gmbh | 64 |
| Pieris Pharmaceuticals Gmbh | 1 |
| Servier Lab | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 65 |
| A61K40/11 | 64 |
| C07K14/4748 | 64 |
| A61K39/0011 | 64 |
| C12Q2600/156 | 64 |